Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8M Buy
12,977
+1
+0% +$1.59K 1.15% 22
2026
Q1
$17.1M Sell
12,976
-2,983
-19% -$4.09M 0.81% 50
2025
Q4
$17.1M Buy
15,959
+588
+4% +$613K 0.82% 53
2025
Q3
$14.9M Buy
15,371
+602
+4% +$473K 0.74% 57
2025
Q2
$11.8M Buy
14,769
+883
+6% +$634K 0.63% 66
2025
Q1
$9.2M Buy
13,886
+2,477
+22% +$1.8M 0.53% 68
2024
Q4
$9.51M Sell
11,409
-93
-0.8% -$66.8K 0.54% 63
2024
Q3
$9.58M Buy
+11,502
New +$10.3M 0.54% 63

Other funds holding ASML

GW Henssler & Associates's ASML Position: Q2 2026 in Review

GW Henssler & Associates increased its ASML (ASML) stake by 0.01% in Q2 2026, buying an estimated $1.59K and bringing the position to 12,977 shares worth $25.8M. The position accounts for 1.15% of the portfolio, ranked #22.

GW Henssler & Associates first reported a position in ASML in Q3 2024 and has held it in 8 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • GW Henssler & Associates held 12,977 shares of ASML worth $25.8M as of Q2 2026.
  • GW Henssler & Associates bought 1 ASML share in Q2 2026, an estimated $1.59K.
  • ASML made up 1.15% of GW Henssler & Associates's portfolio in Q2 2026, its #22 holding.
  • GW Henssler & Associates first reported a position in ASML in Q3 2024 and has held it in 8 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.